CT radiomics nomogram combining vertebral, muscle features shows AUC 0.956 for T2DM diagnosis
This retrospective study investigated the diagnostic value of CT-based radiomics features from vertebral bodies (VB) and paravertebral muscles (PVM) for type 2 diabetes mellitus (T2DM). The study included 160 cases: 80 patients with T2DM and 80 non-diabetic patients. Regions of interest for VB and PVM were delineated, and radiomics features were extracted. Patients were divided into a training group (n=112) and a validation group (n=48) in a 7:3 ratio. Key radiomics features were selected using independent samples t-test and LASSO algorithm. A k-nearest neighbor classifier was used to establish radiomics models, and radiomics scores were calculated. Clinical risk factors were identified via univariate and multivariate logistic regression to build a clinical model. A nomogram was developed by integrating the radiomics score with the clinical model using multivariate logistic regression. Diagnostic performance was evaluated using AUC, calibration curves, and clinical decision curves, with Delong's test for model comparison. In the training set, AUCs were 0.902 for the VB radiomics model, 0.948 for the PVM radiomics model, 0.952 for the VB-PVM combined radiomics model, 0.857 for the clinical model, and 0.956 for the radiomics-clinical combined model. In the validation set, corresponding AUCs were 0.873, 0.880, 0.894, 0.758, and 0.926. The radiomics-clinical combined model showed the best diagnostic performance. Calibration and decision curves indicated the nomogram had good consistency and clinical applicability. The study concluded the combined radiomics and clinical model based on CT images of VB and PVM has good diagnostic value for T2DM differential diagnosis.